Skip to Content
COVID-19 Response and Update
International
Amneal Pharmaceuticals
  • Corporate
  • India
  • About
        • AboutWe challenge convention so healthy can be possible
        • Our Story
          • Amneal at-a-glance
          • Our Founders
          • Our Milestones
        • Our Purpose & Commitments
        • Our Culture
          • Rise, Lead, Succeed
        • Our Leadership
          • Executive Leadership
          • Voices of Leadership
          • Board of Directors
        • Our Locations
        • Responsibility
          • The Amneal Patient Assistance Program
          • Product Donations
          • National and Local Philanthropy
          • Compliance and Ethics
        • Patient Community Connections
          • Our Commitment to Parkinson’s
        • Awards & Recognition
  • Products
        • ProductsWe create essential medicines
        • Our Portfolio
          • Biosciences
          • Generic Products
          • Specialty Products
          • Product Catalog
        • Quality
        • Drug Safety
          • Adverse Event Reporting
          • Medical Inquiries
          • Product Complaints
        • Operations
  • Research & Development
        • Research & DevelopmentWe invest significantly in new product development
        • Generics R&D
        • Specialty R&D
          • Drug Delivery Technologies
        • Product Partnering
  • Investors
        • InvestorsBecome an Informed Investor
        • Financial Reports
          • SEC Filings
          • Annual Reports
          • Quarterly & Other Reports
        • Events & Presentations
        • Stock Information
        • Corporate Governance
          • Policies
          • Executive Officers & Directors
          • Board Committees
        • Investor Resources
          • Analysts
          • Investor FAQ
          • Email Alerts
          • Information Request
          • RSS Feeds
  • News
  • Careers
        • CareersHelp make healthy possible
        • Total Rewards
        • Search Our Career Opportunities
  • Contact
  • Customer Login

Responsibility

Responsibly helping patients live better lives

We make high quality medicines, and we make them accessible. That, by itself, is powerful. But our impact extends well beyond this critical work. Our core ESG priorities, include our commitment to embedding sustainability across our business; human capital management, including well-being, inclusion and belonging efforts; philanthropic partnerships with health-related non-profits; corporate governance and oversight over ESG strategy and risks; and improving access to essential medicines globally.

Read our fourth annual ESG Report which details our progress towards environmental sustainability and contributions toward building healthier communities.
 

Amneal Inaugural Corporate Responsibility Report. We make healthy possible 2022

2023 Environmental, Social and Governance Report

View Previous Reports

Amneal Inaugural Corporate Responsibility Report. We make healthy possible 2022

2022 Environmental, Social and Governance Report

Amneal Inaugural Corporate Responsibility Report. We make healthy possible 2021

2021 Corporate Responsibility Report

Amneal Inaugural Corporate Responsibility Report. We make healthy possible 2021

2020 Corporate Responsibility Report

 

Learn more about our commitment to Responsibility:

Patient Assistance Programs
Patient Assistance Programs
Product Donations
Product Donations
National & Local Philanthropy
National & Local Philanthropy
Compliance & Ethics
Compliance & Ethics
  • Privacy Notice
  • Copyright & Legal Disclaimer
  • Web Accessibility
  • Expanded Access Policy
  • NABP DDA Accreditation
  • Linkedin
  • Twitter
  • Facebook
  • Youtube
© 2025 Amneal Pharmaceuticals LLC.
All rights reserved.